EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing the production and efficacy of antimicrobial bioactive compounds from Streptomyces kanamyceticus in combating multi-drug-resistant pathogens

Zifang Shang, Vipasha Sharma, Liu Pai, Tarun Kumar, Sandip Patil

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2024.1500440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Zifang Shang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Engineering Technological Research Centre of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou Academy of Medical Sciences, Meizhou …. Hauptthemen laut MEDLINE: Streptomyces, Anti-Infective Agents, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rise of antibiotic-resistant pathogens has intensified the search for novel antimicrobial agents. This study aimed to isolate Streptomyces kanamyceticus from local soil samples and evaluate its antimicrobial properties, along with optimizing the production of bioactive compounds.

Methods

Soil samples were collected from local regions, processed, and analysed for Streptomyces strains isolation using morphological characteristics and molecular identification through 16S rRNA gene PCR assay. Antimicrobial activity was assessed against Escherichia coli , Staphylococcus aureus , Bacillus subtilis , and Candida albicans using the double-layer method, while Minimum Inhibitory Concentration (MIC) values were determined. The extracted compounds underwent Fourier Transform Infrared Spectroscopy (FTIR) analysis for functional group identification. Optimization of bioactive compound production was performed using a Central Composite Design (CCD) coupled with Partial Least Squares Regression (PLSR).

Results

A total of 25 distinct Streptomyces strains were isolated, with seven confirmed as S. kanamyceticus . These strains exhibited antimicrobial activity, with inhibition zones reaching 30 mm and MIC values between 20 and 70 µg/mL. The extraction yielded 150-200 mL of bioactive compounds. Optimization studies revealed that a medium containing 10 g/L glucose and 10 g/L glycine max meal maximized antibiotic production.

Conclusion

This study confirmed that S. kanamyceticus is a promising source of novel antibiotics. The combination of microbial isolation, antimicrobial testing, and statistical optimization successfully enhanced the production of bioactive compounds, contributing to the search for effective antimicrobial agents against resistant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesAnti-Infective AgentsAnti-Bacterial AgentsSoil MicrobiologyMicrobial Sensitivity TestsRNA, Ribosomal, 16SCandida albicansStaphylococcus aureusEscherichia coliBacillus subtilisSpectroscopy, Fourier Transform InfraredDrug Resistance, Multiple, BacterialDNA, BacterialCulture Media

Stichwörter der Autor:innen

Streptomyces kanamyceticusantibiotic resistanceantimicrobial activitybioactive compoundsoptimization

Substanzen

RNA, Ribosomal, 16SAnti-Infective AgentsAnti-Bacterial AgentsDNA, BacterialCulture Media

Autor:innen und Institutionen

  • Guangdong Engineering Technological Research Centre of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, China.
  • Department of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India.
  • Department of Haematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China.
  • Mkelly Biotech Pvt Ltd., Mohali, Punjab, India.
  • Paediatric Research Institute, Shenzhen Children's Hospital, Shenzhen, China.

Zitieren

APA

Shang, Z., Sharma, V., Pai, L., Kumar, T., & Patil, S. (2025). Optimizing the production and efficacy of antimicrobial bioactive compounds from Streptomyces kanamyceticus in combating multi-drug-resistant pathogens. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1500440

Vancouver

Shang Z, Sharma V, Pai L, Kumar T, Patil S. Optimizing the production and efficacy of antimicrobial bioactive compounds from Streptomyces kanamyceticus in combating multi-drug-resistant pathogens. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2024.1500440

BibTeX
@article{Shang2025,
  author = {Shang, Zifang and Sharma, Vipasha and Pai, Liu and Kumar, Tarun and Patil, Sandip},
  title = {Optimizing the production and efficacy of antimicrobial bioactive compounds from Streptomyces kanamyceticus in combating multi-drug-resistant pathogens},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2024.1500440}
}
Kostenlos starten →